IRCCS Burlo Garofolo Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2013
NCT02124330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Institute for maternal and child health IRCCS Burlo Garofolo | Institute for Maternal and Child Health - IRCCS "Burlo Garofolo" | IRCCS materno infantile Burlo Garofolo

Active Ingredients

Drugs in Other Trials (3)

lidocaine (xylocaine) (1 trial)

montmorillonite (1 trial)

prilocaine (citanest) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3